Stanford Root

Schedule

Stanford Root

Schedule

LAW 242Z

Discussion (1L): Pharmaceutical Pricing and Access

UNITS:1
GRADING:Law Mandatory P/R/F
LEVEL:Graduate
GER:—

Policymakers across the ideological spectrum describe the U.S. drug pricing system as "broken." But it is less clear how and why the system is broken, or what to do about it. Is the problem that patents delay competition? That Medicare pays the wrong way? That intermediaries distort the market? That fragile supply chains leave patients without needed medicines? That the system rewards the wrong innovations? In this discussion seminar, we will map the basic legal and policy architecture of pharmaceutical pricing and access in the United States and beyond. We will consider four sets of reform proposals: efforts to rein in drug patents, to let the government set prices or rely on prices from other markets, to address the middlemen and supply-chain failures in U.S. markets, and to expand access to medicines abroad. Our aim is to learn how lawyers and policymakers analyze the complex institutional tradeoffs these proposals present. Elements used in grading: Full attendance, reading of assigned materials, and active participation. Class meets: 6:LAW 00 PM-8:LAW 00 PM on Sept. LAW 22, Oct. 6, Oct. LAW 27, Nov LAW 10.

Syllabus for selected term:
View Autumn 2026 Syllabus

Sections

1 Term
Seminar 1Open
ID: 28362
0 / 12 enrolled
Meeting 1 of 4
DAYS:Tuesday
TIME:6 PM – 8 PM
LOCATION:TBD
INSTRUCTOR:
Ouellette, Lisa
Meeting 2 of 4
DAYS:Tuesday
TIME:6 PM – 8 PM
LOCATION:TBD
INSTRUCTOR:
Ouellette, Lisa
Meeting 3 of 4
DAYS:Tuesday
TIME:6 PM – 8 PM
LOCATION:TBD
INSTRUCTOR:
Ouellette, Lisa
Meeting 4 of 4
DAYS:Tuesday
TIME:6 PM – 8 PM
LOCATION:TBD
INSTRUCTOR:
Ouellette, Lisa
1unit

LAW 242Z: Discussion (1L): Pharmaceutical Pricing and Access

1 units · Law Mandatory P/R/F

Policymakers across the ideological spectrum describe the U.S. drug pricing system as "broken." But it is less clear how and why the system is broken, or what to do about it. Is the problem that patents delay competition? That Medicare pays the wrong way? That intermediaries distort the market? That fragile supply chains leave patients without needed medicines? That the system rewards the wrong innovations? In this discussion seminar, we will map the basic legal and policy architecture of pharmaceutical pricing and access in the United States and beyond. We will consider four sets of reform proposals: efforts to rein in drug patents, to let the government set prices or rely on prices from other markets, to address the middlemen and supply-chain failures in U.S. markets, and to expand access to medicines abroad. Our aim is to learn how lawyers and policymakers analyze the complex institutional tradeoffs these proposals present. Elements used in grading: Full attendance, reading of assigned materials, and active participation. Class meets: 6:00 PM-8:00 PM on Sept. 22, Oct. 6, Oct. 27, Nov 10.

Offered in Autumn 2026 at Stanford University.

Autumn 2026 sections

  • Seminar — Tuesday 6:00 PM – 8:00 PM — Ouellette, Lisa (Graduate)

More LAW courses

  • LAW 242T: Discussion (1L): Environmental Democracy: Past, Present, and Future
  • LAW 242U: Discussion (1L): Excursions in Criminal Law
  • LAW 242V: Discussion (1L): Free Speech and Internet Platforms
  • LAW 242W: Discussion (1L): Government Hiring and Firing
  • LAW 242X: Discussion (1L): Is the Market Fair? Technology, Access, and the Law of Modern Finance
  • LAW 242Y: Discussion (1L): On Tyranny: Xenophon's Dialogue and Leo Strauss's Commentary
  • LAW 243A: Discussion (1L): Reading Jonathan Rauch, The Constitution of Knowledge
  • LAW 243B: Discussion (1L): Reexamining Judicial Supremacy
  • LAW 243C: Discussion (1L): The Law and Politics of International Migration
  • LAW 400: Directed Research
  • LAW 403: Senior Thesis
  • LAW 406: Research Track

All LAW courses · All departments